Proactive investorsLogo Proactive Investors UK Website

Search field

1 year chart

digital-look imported chart image

1 day chart

digital-look imported chart image
Epic & Msn data
Epic ASX
Time: 16:29:00
Mid Price: 2878.24
Change Today:
Change % Today:
Fifty Two Week High:
Fifty Two Week Low:
Market Capital:
Period & price data
Period Price
Now: 2878.24
3 Months ago:
6 Months ago:
1 Year ago:
Additional information
Additional Information
Market: All Share Index
Sector: General Mining
Epic: ASX
News: Latest news
Web Site: UK Market Wrap
Other Articles: 16-03-201016-03-201016-03-2010

Monday, October 26, 2009

Oil, Gold and Platinum fall, but FTSE 100 set to rise in early trade

company news image

Overview: the FTSE 100 is projected to open about 20 points higher today, in defiance of Friday’s bearish session on Wall Street, where all of the key indices fell despite another string of positive corporate results from Schlumberger (NYSE: SLB), Honeywell (NYSE: HON), Capital One Financial Corp (NYSE: COF), Amazon (NYSE: AMZN) and Microsoft (NYSE: MSFT), as investors were reaping profits from the gains made over the course of the week.

Asian markets advanced this morning with Hong Kong’s Hang Seng tacking on 1.75%, while the Shanghai composite inched 0.1% higher. Japan’s Nikkei rose 1% to reach four weeks’ highest.

Oil prices were down from Friday’s levels with US benchmark crude easing below US$80/barrel, while Brent Crude fell to US$77.42/barrel.

Precious metals were slightly lower. Gold moved down to US$1,053/oz, Silver was at US$17.68/oz, while Platinum fluctuated around US$1,360/oz.

Base metals, however, moved higher. Copper rose to US$3.03/pound, Nickel improved to US$8.77/pound, while Zinc reached US$1.03/pound.

Morning news wrap

In the FTSE 100, biopharma company Shire (LSE: SHP) said the US Food and Drug Administration (FDA) upheld its prior decision to grant five year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE.

In the FTSE 250, provider of household and personal care products McBride (LSE: MCB) said its trading performance has been ahead of expectations as revenues increased 7%.

Landbrokers (LSE: LAD) said it received acceptances for 95% of the number of new shares in the rights issue announced earlier this month.

In the AIM, Indonesia operating coal miner Churchill Mining (AIM: CHL) said initial JORC probable in situ reserve of 956 million tonnes for the East Kutai gold project.

Eastern Europe focused junior Aurelian Oil & Gas (AIM: AUL) announced a gas sales deal with Kulczyk Investments SA for the gas produced at its Siekierki field in Poland. It also released an update for its Voitinel-1 well in Romania, saying it flowed at an initial rate of 85,000 cubic metres per day .

Australia focused coking coal producer Caledon Resources (AIM: CDN) released a quarterly report, saying production was on schedule to increase in the final quarter results in a forecast production of saleable coal of 500,000 tonnes for the year.

NewsNow icon AddThis Feed Button
Register here to be notified of future UK Market Wrap articles.

Other UK Market Wrap articles

More articles ►

Other UK Market Wrap news

More news ►

Investors interested in UK Market Wrap recently viewed


No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.